Abstract
Aim:
To identify metabolites of ginkgolide B in rat urine, the predominant metabolism of ginkgolide B and the major cytochrome (CYP) P450 enzymes responsible for the metabolism of ginkgolide B in rat liver microsomes.
Methods:
A liquid chromatography quadrupole mass spectrometer and liquid chromatography ion-trap-time-of-fight mass spectrometer with electrospray ionization in negative-ion mode were used for the structure elucidation of metabolites in rat urine and liver microsome incubation. Various selective CYP450 inhibitors were applied to investigate their effects on the metabolism of ginkgolide B and the formation of the major metabolite in rat liver microsomes.
Results:
Three metabolites were identified in rat urine. One hydroxyl metabolite of ginkgolide B were identified in rat liver microsomes, and quinidine uncompetitively inhibited the formation of the metabolite; its inhibitor constant (Ki) value for the inhibition of hydroxyl metabolite was estimated to be 8 μmol/L, while α-naphthoflavone, ketoconazole, sulfaphenazole, and diethyldithiocarbamate had no inhibitory effects.
Conclusion:
Ginkgolide B was metabolized to its hydroxyl metabolite in rats, and CYP2D6 was the major rat CYP isoform responsible for the ginkgolide B metabolism in rat liver microsomes.
Similar content being viewed by others
Article PDF
References
Braquet P . Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Adv Prostaglandin Thromboxane Leukot Res 1986; 16: 179–98.
Prehn JH, Krieglstein J . Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res 1993; 34: 179–88.
Liu XH, Eun BL, Silverstein FS, Barks JD . The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr Res 1996; 40: 797–803.
Koch E . Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Phytomedicine 2005; 12: 10–6.
Beck JC, Goodner CJ, Wilson C, Wilson D, Glidden D, Baskin DG, et al. Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat. Autoimmunity 1991; 9: 225–35.
Oberpichler H, Sauer D, Rossberg C, Mennel HD, Krieglstein J . PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus. J Cereb Blood Flow Metab 1990; 10: 133–5.
Bate C, Salmona M, Williams A . Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β1-42. J Neuroinfammation 2004; 1: 4–11.
Chen WD, Liang Y, Xie L, Lu T, Liu XD, Wang GJ . Pharmacokintics of the ginkgo B following intravenous administration of ginkgo B emulsion in rats. Biol Pharm Bull 2007; 30: 1–5.
Liu XQ, Zhao Y, Li D, Qian ZY, Wang GJ . Metabolism and metabolic inhibition of clinipine in human liver microsomes. Acta Pharmacol Sin 2003; 24: 263–8.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ . Protein measurement with the folin-phenol reagent. J Biol Chem 1951; 193: 265–75.
Liu YT, Hao K, Liu XQ, Wang GJ . Metabolism and metabolic inhibition of gambogic acid in rat liver microsomes. Acta Pharmacol Sin 2006; 27: 1253–8.
Van Beek TA . Ginkgolides and bilobalide: Their physical, chromatographic and spectroscopic properties. Bioorg Med Chem 2005; 13: 5001–12.
Suehiro M, Simpson NR, Underwood MD, Castrillon J, Nakanishi K, Van Heertum R . In vivo biodistribution of ginkgolide B, a constituent of Ginkgo biloba, visualized by MicroPET. Planta Med 2005; 71: 622–7.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Hi-Tech Research and Development Program of China “863” (No 2003AA 2Z347A) and Jiangsu Key Laboratory of Drug Metabolism and Pharmacokinetics (No BM2001201).
Rights and permissions
About this article
Cite this article
Wang, Dl., Liang, Y., Chen, Wd. et al. Identification of ginkgolide B metabolites in urine and rat liver cytochrome P450 enzymes responsible for their formation in vitro. Acta Pharmacol Sin 29, 376–384 (2008). https://doi.org/10.1111/j.1745-7254.2008.00758.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00758.x
Keywords
This article is cited by
-
Profiling of phenolic acids, flavonoids, terpenoids, and steroid derivatives in coconut (Cocos nucifera L.) haustorium
Food Science and Biotechnology (2023)
-
Understanding the regioselective hydrolysis of ginkgolide B under physiological environment based on generation, detection, identification, and semi-quantification of the hydrolyzed products
Analytical and Bioanalytical Chemistry (2015)
-
Semi-quantitative determination of monocarboxylate forms of ginkgolide B in plasma by UPLC-MS
Analytical and Bioanalytical Chemistry (2015)
-
Ginkgo biloba Extracts: A Review of the Pharmacokinetics of the Active Ingredients
Clinical Pharmacokinetics (2013)
-
Characterization of cardamonin metabolism by P450 in different species via HPLC-ESI-ion trap and UPLC-ESI-quadrupole mass spectrometry
Acta Pharmacologica Sinica (2009)